Paliperidone Palmitate
Brand name: Invega Sustenna
Rank #20 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$832.3M
Total Cost
252,388
Total Claims
$832.3M
Total Cost
6,783
Prescribers
$3,298
Cost per Claim
14,341
Beneficiaries
278,371
30-Day Fills
$123K
Avg Cost/Provider
37
Avg Claims/Provider
Share of Medicare Part D Spending
0.30%
of total Medicare Part D spending
$832.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $832.3M total
🔎 Data Overview
Ranked #20 out of 500 drugs tracked by total cost. Paliperidone Palmitate represents a significant portion of Medicare drug spending.
At $3,298 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $122,697 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $58,033 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Paliperidone Palmitate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Brett Gurkin | Psychiatry | Wilmington, NC | 529 | $1.7M |
| 2 | David Kieta | Nurse Practitioner | Uniontown, PA | 415 | $1.4M |
| 3 | Shephali Patel | Psychiatry | Chicago, IL | 437 | $1.3M |
| 4 | Vonda Gravely | Psychiatry | Spartanburg, SC | 406 | $1.3M |
| 5 | Robert Morton | Psychiatry | Ada, OK | 383 | $1.3M |
| 6 | Ramon Sanchez | Psychiatry | San Antonio, TX | 380 | $1.2M |
| 7 | Valerie Rumple | Nurse Practitioner | Fort Wayne, IN | 393 | $1.2M |
| 8 | Manojbhai Patel | Psychiatry | Washington, PA | 375 | $1.2M |
| 9 | Ravindranath Kolli | Psychiatry | Monessen, PA | 351 | $1.1M |
| 10 | Sarabjit Sandhu | Psychiatry | Newport Beach, CA | 326 | $1.1M |
| 11 | Marija Petrovic | Psychiatry | Alexandria, VA | 316 | $1.0M |
| 12 | Anissa Thomas | Nurse Practitioner | Birmingham, AL | 344 | $994K |
| 13 | Joshua Eslami | Nurse Practitioner | Montgomery, AL | 293 | $989K |
| 14 | Ollie Combs | Nurse Practitioner | Madisonville, KY | 293 | $985K |
| 15 | Yuliya Spencer | Nurse Practitioner | Birmingham, AL | 318 | $966K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 17 | Tirzepatide (Mounjaro) | $877.9M | 680,457 |
| 18 | Ibrutinib (Imbruvica) | $875.8M | 56,368 |
| 19 | Ustekinumab (Stelara) | $852.3M | 31,974 |
| 20 | Paliperidone Palmitate (Invega Sustenna) | $832.3M | 252,388 |
| 21 | Insulin Aspart (Novolog Flexpen) | $831.6M | 958,823 |
| 22 | Budesonide/Formoterol Fumarate (Symbicort) | $759.4M | 1,452,561 |
| 23 | Palbociclib (Ibrance) | $755.1M | 48,329 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology